Migliorini P, Boulanger N, Betschart B, Corradin G
Institut of Biochemistry, University of Lausanne, Epalinges, Switzerland.
Scand J Immunol. 1990 Feb;31(2):237-42. doi: 10.1111/j.1365-3083.1990.tb02764.x.
In the murine malaria model induced by Plasmodium berghei, we studied the immunogenicity of the repeat region of the circumsporozoite (CS) protein, which is the main target of the antibody response in infected animals. We immunized several strains with a synthetic peptide--Y(DPPPPNPN)3--corresponding to one of the two P. berghei repeat sequences in complete Freund's adjuvant. Only C57BL/6 immune sera reacted with the synthetic peptide in ELISA and with the native CS protein on P. berghei sporozoites, as detected by immunofluorescence. From lymph node cells of immunized C57BL/6 we isolated two repeat-specific T-cell lines which proliferated in the presence of the synthetic peptide or the recombinant CS protein. We analysed the protective role of this repeat-specific response by injecting infectious sporozoites into mice immunized with irradiated sporozoites or with the repeat peptide. The percentage of mice developing parasitaemia was 80-90% in the peptide-immunized group and only 10-20% in the group immunized with irradiated sporozoites. Anti-repeat antibody titres were comparable in the two groups. On the basis of these results, we can conclude that the T- and B-cell response to the CS repeat obtained with this synthetic peptide immunization is not sufficient for a protective immunity.
在伯氏疟原虫诱导的小鼠疟疾模型中,我们研究了环子孢子(CS)蛋白重复区域的免疫原性,该区域是感染动物体内抗体反应的主要靶点。我们用一种合成肽——Y(DPPPPNPN)3——免疫了多个品系,该合成肽对应于伯氏疟原虫两个重复序列之一,免疫佐剂为完全弗氏佐剂。通过酶联免疫吸附测定(ELISA)检测发现,只有C57BL/6免疫血清能与合成肽发生反应,通过免疫荧光检测发现,其能与伯氏疟原虫子孢子上的天然CS蛋白发生反应。我们从免疫后的C57BL/6小鼠的淋巴结细胞中分离出两条重复序列特异性T细胞系,它们在合成肽或重组CS蛋白存在的情况下能够增殖。我们通过将感染性子孢子注射到用辐照子孢子或重复肽免疫的小鼠体内,分析了这种重复序列特异性反应的保护作用。在肽免疫组中,出现寄生虫血症的小鼠百分比为80 - 90%,而在辐照子孢子免疫组中仅为10 - 20%。两组的抗重复抗体滴度相当。基于这些结果,我们可以得出结论,用这种合成肽免疫获得的针对CS重复序列的T细胞和B细胞反应不足以产生保护性免疫。